ARKF vs. CRVS
ARKF (ARK Fintech Innovation ETF) is Blockchain fund actively managed by ARK, while CRVS (Corvus Pharmaceuticals, Inc.) is a stock. Over the past 5 years, ARKF returned -5.06%/yr vs 33.63%/yr for CRVS. At a 0.34 correlation, their price movements are largely independent.
Performance
ARKF vs. CRVS - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ARKF achieves a -18.31% return, which is significantly lower than CRVS's 54.94% return.
ARKF
- 1D
- 0.00%
- 1M
- -5.76%
- YTD
- -18.31%
- 6M
- -21.31%
- 1Y
- -11.87%
- 3Y*
- 23.97%
- 5Y*
- -5.06%
- 10Y*
- —
CRVS
- 1D
- 2.84%
- 1M
- -24.68%
- YTD
- 54.94%
- 6M
- 42.53%
- 1Y
- 181.37%
- 3Y*
- 53.32%
- 5Y*
- 33.63%
- 10Y*
- 0.06%
ARKF vs. CRVS - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|---|---|---|
ARKF ARK Fintech Innovation ETF | -18.31% | 28.67% | 34.34% | 93.27% | -65.07% | -17.82% | 108.03% | 20.45% |
CRVS Corvus Pharmaceuticals, Inc. | 54.94% | 43.93% | 203.98% | 107.06% | -64.73% | -32.30% | -34.56% | 34.99% |
Correlation
The correlation between ARKF and CRVS is 0.29, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.29 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.32 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.36 |
Correlation (All Time) Calculated using the full available price history since Feb 4, 2019 | 0.34 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ARKF vs. CRVS — Risk / Return Rank
ARKF
CRVS
ARKF vs. CRVS - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for ARK Fintech Innovation ETF (ARKF) and Corvus Pharmaceuticals, Inc. (CRVS). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| ARKF | CRVS | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.37 | ||
| Sortino ratioReturn per unit of downside risk | -4.52 | ||
| Omega ratioGain probability vs. loss probability | 0.97 | 1.48 | -0.51 |
| Calmar ratioReturn relative to maximum drawdown | -0.31 | 3.23 | -3.54 |
| Martin ratioReturn relative to average drawdown | -0.57 | 7.03 | -7.60 |
Loading charts...
Drawdowns
ARKF vs. CRVS - Drawdown Comparison
The maximum ARKF drawdown since its inception was -78.63%, smaller than the maximum CRVS drawdown of -96.97%. Use the drawdown chart below to compare losses from any high point for ARKF and CRVS.
Loading charts...
Drawdown Indicators
| ARKF | CRVS | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -78.63% | -96.97% | +18.34% |
Max Drawdown (1Y)Largest decline over 1 year | -38.50% | -56.43% | +17.93% |
Max Drawdown (3Y)Largest decline over 3 years | -38.50% | -70.50% | +32.00% |
Max Drawdown (5Y)Largest decline over 5 years | -75.30% | -92.40% | +17.10% |
Max Drawdown (10Y)Largest decline over 10 years | — | -96.97% | — |
Current DrawdownCurrent decline from peak | -38.77% | -53.25% | +14.48% |
Average DrawdownAverage peak-to-trough decline | -34.95% | -69.28% | +34.33% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 21.00% | 25.91% | -4.91% |
Volatility
ARKF vs. CRVS - Volatility Comparison
The current volatility for ARK Fintech Innovation ETF (ARKF) is 10.36%, while Corvus Pharmaceuticals, Inc. (CRVS) has a volatility of 23.12%. This indicates that ARKF experiences smaller price fluctuations and is considered to be less risky than CRVS based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ARKF | CRVS | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 10.36% | 23.12% | -12.76% |
Volatility (6M)Calculated over the trailing 6-month period | 25.14% | 111.88% | -86.74% |
Volatility (1Y)Calculated over the trailing 1-year period | 33.69% | 180.64% | -146.95% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 42.87% | 131.02% | -88.15% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 39.77% | 111.13% | -71.36% |
Dividends
ARKF vs. CRVS - Dividend Comparison
ARKF's dividend yield for the trailing twelve months is around 0.11%, while CRVS has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
ARKF ARK Fintech Innovation ETF | 0.11% | 0.09% | 0.00% | 0.00% | 0.00% | 0.00% | 0.37% | 1.25% |
CRVS Corvus Pharmaceuticals, Inc. | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Frequently Asked Questions
ARKF and CRVS have a correlation of 0.29, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
CRVS has higher volatility (23.12%) compared to ARKF (10.36%). In terms of maximum drawdown, ARKF dropped -78.63% vs CRVS's -96.97%.
CRVS currently has the higher Sharpe Ratio (1.01 vs -0.35), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ARKF and CRVS
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer